Open comment allows key stakeholders to critically review and identify any errors or gaps in a draft guideline prior to its finalization and publication. It allows for greater transparency in the ASCO ...

All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each ...

All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each ...

This section provides key information on oncology events organized by ASCO or other organizations throughout the world. To submit an event, please fill out this form. Content on ASCO's Calendar of ...

ALEXANDRIA, Va. – The global oncology community will gather in Chicago and online to discuss the latest cutting-edge cancer research at the 2026 American Society of Clinical Oncology (ASCO) Annual ...

The LBCA-Shannon Klingman Lobular Breast Cancer Clinical Research Grants provide funding to encourage and promote quality research in oncology with a focus on invasive lobular breast cancer. Invasive ...

Based on funding availability, a limited number of Merit Awards will be awarded to eligible trainees and students whose research is addressed in high-quality abstracts submitted to an ASCO Meeting and ...

Conquer Cancer®, the ASCO Foundation and Pfizer Inc. are collaborating to offer a Quality Improvement grant funding opportunity for healthcare systems, hospitals, cancer centers and other patient care ...

The 2025 ASCO Annual Meeting begins in just nine days, and we look forward to seeing you in Chicago. As you plan your schedule, consider joining the Association for Clinical Oncology’s advocacy events ...

ASCO is urging lawmakers to ensure America continues to lead in research through continued bipartisan support for federal health agencies and the scientists driving daily progress. Ahead of the April ...

Several presidential appointees have been confirmed to lead key health agencies that the Association for Clinical Oncology (ASCO) will work with during the new administration. These include: Robert F.